🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Electroacupuncture vs. Auricular Acupressure vs. Waitlist Control for Breast Cancer Endocrine Therapy-Related Joint Pain

RecruitingNAAges 18 Years - 75 YearsFemaleFirst Teaching Hospital of Tianjin University of …
NCT07490938 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The purpose of this pragmatic, multicenter, randomized controlled trial is to evaluate the clinical effectiveness and safety of electroacupuncture and auricular acupressure for improving joint pain related to endocrine therapy in breast cancer patients. A total of 200 participants will be recruited and randomly assigned to one of three groups: the Electroacupuncture Group (n=80), the Auricular Acupressure Group (n=80), or the Waitlist Control Group (n=40), using a central stratified block randomization method. The primary objective is to compare changes in Worst Pain Item score among the three groups from baseline to the end of the treatment period, as measured by the Brief Pain Inventory-Short Form (BPI-SF). Secondary objectives include assessing pain interference, overall health status through the PROMIS scale, and quality of life specifically related to endocrine therapy using the FA

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Histologically or cytologically confirmed breast cancer, stage I-IV, according to the AJCC Cancer Staging Manual (8th edition); * Aged 18-75 years; * Experiencing joint pain attributed to endocrine therapy, including localized or generalized joint pain, with symptoms persisting for at least 1 week; * Completion of all planned surgeries, chemotherapy, and radiotherapy, with a scheduled continuation of endocrine therapy for at least 1 additional year; * Self-reported worst joint pain score of ≥3 on a 0-10 Visual Analogue Scale (VAS) during the past week; * Life expectancy ≥1 year; * Voluntarily sign the informed consent. Exclusion Criteria: * Bone metastases involving the same site as the affected joint attributed to endocrine therapy; * History of fracture or surgery involving the affected joints within the past 6 months; * Implanted electronic medical devices; * Not suitable for acupuncture, including but not limited to bleeding tendencies (e.g. coagulation disorders or purpura) or local skin lesions at the intended acupoint sites.
💊

What it tests

  • Electroacupuncture Group
  • Auricular Acupressure Group
📍

Where

6 sites
Hubei Cancer Hospital
Wuhan, China
First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
Tianjin, China
Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital
Tianjin, China
Tianjin Medical University Cancer Institute & Hospital
Tianjin, China
Affiliated Hospital of Qinghai University
Xining, China
Qinghai Provincial Hospital of Traditional Chinese Medicine
Xining, China
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy